Pimstone Simon N.'s Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Jun 1, 2023
- Accession no.
- 0000950170-23-025802
- Filed
- Jun 1, 2023
- Trade date
- May 30-Jun 1, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 15 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.10M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pimstone Simon N.CIK 0001620084 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | Common Shares | SSaleDisposed | −18,006 | $38.63 | −$695,571.78 | 37,000 | Direct | |
| May 30, 2023 | Common Shares | SSaleDisposed | −19,000 | $39.90 | −$758,100 | 18,000 | Direct | |
| May 31, 2023 | Common Shares | SSaleDisposed | −12,000 | $38.53 | −$462,360 | 6,000 | Direct | |
| May 31, 2023 | Common Shares | MOption exerciseAcquired | +29,835 | $9.85 | +$293,874.75 | 35,835 | Direct | |
| May 31, 2023 | Common Shares | FTax withholdingDisposed | −6,165 | $38.37 | −$236,551.05 | 29,670 | Direct | |
| May 31, 2023 | Common Shares | SSaleDisposed | −23,670 | $38.81 | −$918,632.7 | 6,000 | Direct | |
| May 31, 2023 | Common Shares | MOption exerciseAcquired | +50,000 | $17.76 | +$888,000 | 56,000 | Direct | |
| May 31, 2023 | Common Shares | FTax withholdingDisposed | −23,144 | $38.37 | −$888,035.28 | 32,856 | Direct | |
| May 31, 2023 | Common Shares | SSaleDisposed | −26,856 | $38.69 | −$1,039,058.64 | 6,000 | Direct | |
| Jun 1, 2023 | Common Shares | MOption exerciseAcquired | +9,318 | $7.69 | +$71,655.42 | 15,318 | Direct | |
| Jun 1, 2023 | Common Shares | FTax withholdingDisposed | −1,860 | $38.53 | −$71,665.8 | 13,458 | Direct | |
| Jun 1, 2023 | Common Shares | SSaleDisposed | −7,458 | $38.97 | −$290,638.26 | 6,000 | Direct | |
| Jun 1, 2023 | Common Shares | MOption exerciseAcquired | +45,000 | $17.76 | +$799,200 | 51,000 | Direct | |
| Jun 1, 2023 | Common Shares | FTax withholdingDisposed | −20,745 | $38.53 | −$799,304.85 | 30,255 | Direct | |
| Jun 1, 2023 | Common Shares | SSaleDisposed | −24,255 | $38.78 | −$940,608.9 | 6,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Common Shares | MOption exerciseDisposed | −29,835 | $0.00 | $0 | 0 | Direct | |
| May 31, 2023 | Common Shares | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 45,000 | Direct | |
| Jun 1, 2023 | Common Shares | MOption exerciseDisposed | −9,318 | $0.00 | $0 | 30,682 | Direct | |
| Jun 1, 2023 | Common Shares | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.